Optometry Connection July 2026

Optometry Connection July 2026

Available from: 1/07/2026 (AEST)

Where to publish: https://lms.optometry.org.au/course/view.php?id=1020

Provider: OA National Provider

Contact: Optometry Australia Optometry Australia, [E] cpd@optometry.org.au, [P] 96688550

Activity Outline

Optometrist reads Optometry Connection educational publication in print or online.Optometrist logs into OA Institute of Excellence and completes assessment questions developed from articles in Optometry Connection.

Optometrist will receive immediate confirmation upon completion and CPD Hours will be uploaded to the Learning Plan of their CPD Portfolio. Optometrists completing online assessment will be able to review incorrect answers and have an opportunity to repeat the assessment activity in line with adult learning principles and OBA guidelines. Opportunity to provide feedback and commentary provided by standard OA Institute of Excellence CPD Activity Feedback Form.

Learning Objectives

• Understand the role of oral therapeutics in the management of dry eye disease and meibomian gland dysfunction.
• Understand supporting nutritional and dietary interventions in dry eye disease
• Understand the importance of optometrists as part of managing corneal neuropathic pain
• Recognise the key clinical features of Sjogren’s syndrome aqueous deficient dry eye and implement an evidence-based management approach, including appropriate escalation of treatment, follow up and, multidisciplinary referral where indicate
• Understand the key changes to the definition and diagnosis of dry eye disease
• Select appropriate clinical tests to diagnose dry eye disease
• Describe lifestyle modifications as part of a management plan for dry eye disease
• Compare and select the most appropriate energy-based treatment modality for a patient with MGD, based on meibum viscosity, disease severity, blink mechanics, and skin type -using the evidence hierarchy to justify clinical choices
• Identify contraindications and clinical cautions for applying thermal-based therapies in patients with ocular rosacea, and describe the correct sequencing of anti-inflammatory treatment prior to initiating in-office energy-based therapy
• Design a multimodal MGD management plan that integrates in-office treatment with evidence-based adjunctive therapies - including topical ciclosporin, omega-3 supplementation, and blink rehabilitation -tailored to patient phenotype and severity
• Understand the risk factors, prevention strategies, clinical assessment and multidisciplinary management of abusive head trauma in infants

Max CPD hours awarded: 5

Session Information